| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin lambda variable 6-57 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
ZFP91-CNTF readthrough (NMD candidate) |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||||
|
PR/SET domain 15 | 8.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||||
|
olfactory receptor family 10 subfamily Q member 2 pseudogene |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||||
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | 0.890 | 0.077 | 0.92 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
chromosome 1 open reading frame 56 | 0.931 | 0.077 | 9.7E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
serine peptidase inhibitor Kazal type 2 | 0.890 | 0.077 | 7.0E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
InaF motif containing 2 | 0.890 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
keratin 222 | 0.931 | 0.115 | 1.4E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
immunoglobulin heavy variable 3-41 (pseudogene) | 0.890 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin heavy joining 5 | 0.890 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
immunoglobulin kappa variable 3-15 | 0.931 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
UTP3 small subunit processome component | 0.839 | 0.115 | 1.9E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 43 member 1 | 0.839 | 0.115 | 8.0E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class K | 0.839 | 0.154 | 1.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ring finger and CCCH-type domains 1 | 0.821 | 0.154 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ligand of numb-protein X 2 | 0.861 | 0.154 | 7.3E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
tetratricopeptide repeat domain 41, pseudogene | 0.890 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
pleckstrin homology domain containing A2 | 0.861 | 0.154 | 0.84 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
zinc finger protein 32 | 0.861 | 0.154 | 3.3E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
elongation factor for RNA polymerase II 3 | 0.890 | 0.154 | 1.7E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ZFP91 zinc finger protein | 0.780 | 0.154 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
calcium modulating ligand | 0.769 | 0.154 | 6.2E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
deoxyhypusine hydroxylase | 0.743 | 0.154 | 1.6E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ROR1 antisense RNA 1 | 0.751 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 |